SAVACassava Sciences, Inc.

$116M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$89M

Operating Income

-$106M

Net Income

-$97M

EPS (Diluted)

$-2.32

Cash Flow

Operating Cash Flow

-$82M

Free Cash Flow

-$82M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$152M

Total Liabilities

$14M

Stockholders' Equity

$137M

Cash & Equivalents

$121M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$89M	-$68M	-31.4%
Operating Income	-$106M	-$80M	-32.4%
Net Income	-$97M	-$76M	-27.5%

SAVA FY 2023 Earnings — Cassava Sciences, Inc. Revenue & Financial Results | Market Cap Arena